Barbara Gulanski

Dr. Barbara Gulanski is a Clinical Associate Professor of Medicine at Yale School of Medicine, specializing in endocrinology with a focus on metabolic bone disorders and transgender healthcare. She holds affiliations with the Yale Bone Center and the Department of Internal Medicine, and serves as Associate Chief for Education in the Section of Endocrinology. Her academic roles include leadership in clinical research, education, and institutional initiatives.

Education: MD from New York University (1982), MPH from Yale School of Public Health (1999), Residency at Temple University Hospital (1985).

Research Interests: Diabetes management, cardiometabolic risk factors, fracture prediction in osteoporosis, digital health interventions, and healthcare equity. She leads studies in the GRADE trial evaluating diabetes therapies and contributes to transgender healthcare access initiatives.

Recent Research Trends: Focused on disparities in diabetes care (e.g., racial gaps in glucose monitoring), bone health in HIV patients, and cognitive impacts of diabetes. Active in translational research bridging clinical practice and population health.

Grants/Advising: Co-led Yale's CTSA grant for the Yale Center for Clinical Investigation. Mentored teams in clinical trials at VA Connecticut Healthcare System. Currently oversees educational programs in endocrinology.

Labs/Teams: Involved in the Clinical and Translational Science Award (CTSA) program, Glycemia Reduction Approaches in Diabetes (GRADE) study, and transgender medicine program development at Yale Health.